2009
ANNUAL REPORTIn 2009, Utah Medical Products, Inc. (UTMD) shareholders were rewarded
with a 34% increase in share price and about a 4% cash dividend based
on average share price during the
year.
2008
ANNUAL REPORTDespite the difficult current economic environment and challenging operational year in 2009, I am confident in UTMD’s ability to survive and continue its long term performance of providing excellent shareholder returns.
2007
ANNUAL REPORTFor more than a decade, UTMD's product/market strategy has been a
pursuit of the development, manufacture and marketing of medical devices
that improve the quality of cost-effective care, based on a value-added
rather than commodity-oriented approach.
2006
ANNUAL REPORT
In 2006, Utah Medical Products, Inc. (UTMD) accomplished its plan
as outlined in last year's Management's Discussion and Analysis (MD&A)
section of this annual report. As a result, the Company was able to
return capital to its shareholders in the form of cash dividends in
the amount of $.74 per share, representing a 21% increase over the
2005 dividend.
2005
ANNUAL REPORT
In 2005, Utah medical Products, Inc. (UTMD) continued to effectively
execute its mission of providing high quality, safe and effective
products that help physicians and nurses protect the health of women
and their children.
In regard to financial performance, 2005 sales and gross profits increased
5% compared to the prior year, yielding earnings per share (eps) of
$1.80. Dividends of $.63 per share were paid to shareholders, while
the Company also repurchased about 9% of its shares in the open market
for $8.6 million, an average cost of $23.09 per share repurchased.
